Manuscript Review Cardiology Journals: What Reviewers Expect

Circulation, published by the American Heart Association, is the broadest of the top cardiology journals in terms of scope. It publishes original clinical research, mechanistic studies, translational research, and clinical trials across all cardiovascular disease areas. A strong Circulation paper typically has one of the following: a large well-powered clinical study that changes risk stratification or treatment decision-making; a mechanistic study that identifies a new target with clear translational relevance; or a randomized trial that establishes or modifies a treatment recommendation.

Reviewers at Circulation are particularly focused on statistical rigor. The American Heart Association has explicit statistical standards for the journals it publishes, and manuscripts with underpowered primary endpoints, inappropriate statistical tests, or insufficient adjustment for confounders in observational studies face immediate scrutiny. A biostatistician or statistician review during pre-submission preparation is often warranted for large clinical studies.

EHJ, published by Oxford University Press for the European Society of Cardiology, has historically favored large registry studies, population-based cardiovascular epidemiology, and European clinical trial data. It places significant weight on population size and follow-up duration. A registry study with 100,000 patients and 10-year follow-up is a stronger fit than a mechanistic study with the same scientific insight, other things being equal.

EHJ reviewers are also attentive to international representativeness. Studies limited to single-center European populations face questions about generalizability. Multi-country European studies or comparisons between European and non-European populations have a natural fit with the journal's readership and scope.

The Journal of the American College of Cardiology has a slightly broader acceptance rate than Circulation or EHJ but maintains high scientific standards. It's particularly strong in interventional cardiology, imaging, and heart failure. JACC also publishes several subspecialty journals (JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology) that can be appropriate targets when the primary journal is not the right fit.

JACC reviewers focus heavily on clinical relevance and practice implications. A paper that reports an interesting finding without a clear statement of what it means for how cardiologists should manage patients is unlikely to succeed at JACC. The clinical takeaway needs to be explicit.

Circulation Research is the AHA's mechanistic cardiovascular research journal. It covers basic and translational science - molecular mechanisms, animal models, cell biology of cardiovascular disease, and early translational studies. Papers published here need strong mechanistic evidence and clear cardiovascular disease relevance but don't need the clinical data that Circulation requires.

Pre-submission review by a scientist with cardiology research experience covers the dimensions that determine acceptance or desk rejection at these journals. The specific areas are:

Novelty relative to the recent literature. Cardiology is a high-output field. Major clinical associations, new risk factors, and treatment comparisons are reported constantly. A reviewer at Circulation knows what was published in the last 12 months across all the major cardiology journals. Pre-submission review identifies whether your central finding is genuinely new or whether very similar work has recently been published that your manuscript needs to directly address.

Statistical design and power. For clinical studies, the statistical approach requires specific scrutiny before submission. Sample size justification, primary endpoint definition, adjustment for confounders, and handling of missing data are all evaluated by peer reviewers. Manusights reviewers with cardiology research backgrounds apply the same statistical standards that journal reviewers use. This is particularly important for observational studies, where causal inference requires careful methodological framing.

Clinical significance framing. The manuscript needs to make the clinical management implication explicit, not implied. "These findings suggest that X may be considered in the management of Y" is insufficient. "These findings support measuring X in patients with Y before initiating Z" is the kind of specific clinical takeaway that passes the significance test at Circulation and JACC.

Figure quality and data presentation. Kaplan-Meier curves, forest plots, and multivariate regression tables need to be presented clearly and completely. Reviewers look for missing confidence intervals, improperly labeled axes, sample sizes not shown at each time point in survival analyses, and subgroup analyses without appropriate statistical correction. Catching these before submission prevents preventable revision requests.

In our pre-submission review work, the cardiology drafts that look strongest internally often still fail on two issues. Either the statistics are defensible but the paper does not tell a broad enough clinical story for Circulation or EHJ, or the clinical signal is interesting but the abstract and figures do not make the management consequence legible fast enough.

According to Circulation author instructions, the AHA journals apply explicit statistical expectations to submitted work. European Heart Journal instructions also ask authors to provide a concise summary that helps the editorial team evaluate and process the paper. Those are not cosmetic requirements. They reflect the same editorial screen we see in strong and weak cardiology submissions: if the statistical logic and the clinical story are not obvious early, the paper usually stalls before review gets productive.

To learn about the broader process of avoiding desk rejection, or how to structure revisions after receiving reviewer comments, see our guides on manuscript revision and responding to reviewers.

The most frequent scientific gaps seen in cardiology manuscripts targeting the top tier are predictable. Knowing them in advance makes pre-submission review faster and more targeted.

For clinical studies: underpowered subgroup analyses presented with the same confidence as the primary endpoint; observational associations claimed as causal without appropriate instrumental variable or Mendelian randomization analysis; single-center studies that lack generalizability discussion; follow-up periods too short to capture the clinical outcome of interest.

For translational studies: mouse models with known limitations not adequately addressed; mechanistic findings with no validation in human tissue samples; therapeutic target claims without pharmacological proof-of-concept data; missing rescue experiments to confirm specificity.

For review articles and meta-analyses: heterogeneity statistics not reported or not discussed; PRISMA guidelines not followed; publication bias analysis absent; sensitivity analyses not conducted.

A Manusights reviewer with a cardiology research background identifies which of these apply to your specific manuscript before you invest in a submission. For researchers targeting Circulation, EHJ, or JACC for the first time, a AI Diagnostic is a cost-effective first pass that surfaces the major structural and scientific issues quickly. See manuscript readiness check for details.